Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David J Portman

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
Menopause (New York, N.Y.)|April 23, 2024
Oral lasofoxifene's effects on moderate to severe vaginal atrophy in postmenopausal women: two phase 3, randomized, controlled trialsRisa Kagan, James A Simon, Steven R Goldstein, et al.
Menopause (New York, N.Y.)|September 19, 2013
Low-dose paroxetine 7.5 mg for menopausal vasomotor symptoms: two randomized controlled trialsJames A Simon, David J Portman, Andrew M Kaunitz, et al.
Contraception|December 23, 2017
The emerging role of obesity in short-acting hormonal contraceptive effectivenessAlison Edelman, James Trussell, Abigail R A Aiken, et al.
Journal of Women'S Health (2002)|April 24, 2008
A retrospective managed care claims data analysis of medication adherence to vaginal estrogen therapy: implications for clinical practiceLee P Shulman, David J Portman, Won Chan Lee, et al.
Clinical Breast Cancer|January 19, 2025
Effects of Lasofoxifene Versus Fulvestrant on Vaginal and Vulvar Symptoms in Patients With ESR1-Mutated, ER+/HER2-, Metastatic Breast Cancer From the ELAINE 1 StudyShari B Goldfarb, Sarah L Sammons, Jane L Meisel, et al.
Menopause (New York, N.Y.)|March 4, 2015
Treatment of pain at sexual activity (dyspareunia) with intravaginal dehydroepiandrosterone (prasterone)David F Archer, Fernand Labrie, Céline Bouchard, et al.
Menopause (New York, N.Y.)|December 12, 2018
Women's experience of vulvovaginal symptoms associated with menopauseJan L Shifren, Rebekah Zincavage, Ellen L Cho, et al.
Women'S Health (London, England)|May 17, 2016
Bremelanotide for female sexual dysfunctions in premenopausal women: a randomized, placebo-controlled dose-finding trialAnita H Clayton, Stanley E Althof, Sheryl Kingsberg, et al.
Menopause (New York, N.Y.)|May 14, 2015
Lack of effect of intravaginal dehydroepiandrosterone (DHEA, prasterone) on the endometrium in postmenopausal womenDavid J Portman, Fernand Labrie, David F Archer, et al.
Future Oncology (London, England)|April 13, 2025
ELAINE 3: phase 3 study of lasofoxifene plus abemaciclib to treat ER+/HER2-, <i>ESR1</i>-mutated, metastatic breast cancerMatthew P Goetz, Seth A Wander, Thomas Bachelot, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Menopause (New York, N.Y.)|April 23, 2024
Oral lasofoxifene's effects on moderate to severe vaginal atrophy in postmenopausal women: two phase 3, randomized, controlled trialsRisa Kagan, James A Simon, Steven R Goldstein, et al.
Menopause (New York, N.Y.)|September 19, 2013
Low-dose paroxetine 7.5 mg for menopausal vasomotor symptoms: two randomized controlled trialsJames A Simon, David J Portman, Andrew M Kaunitz, et al.
Contraception|December 23, 2017
The emerging role of obesity in short-acting hormonal contraceptive effectivenessAlison Edelman, James Trussell, Abigail R A Aiken, et al.
Journal of Women'S Health (2002)|April 24, 2008
A retrospective managed care claims data analysis of medication adherence to vaginal estrogen therapy: implications for clinical practiceLee P Shulman, David J Portman, Won Chan Lee, et al.
Clinical Breast Cancer|January 19, 2025
Effects of Lasofoxifene Versus Fulvestrant on Vaginal and Vulvar Symptoms in Patients With ESR1-Mutated, ER+/HER2-, Metastatic Breast Cancer From the ELAINE 1 StudyShari B Goldfarb, Sarah L Sammons, Jane L Meisel, et al.
Menopause (New York, N.Y.)|March 4, 2015
Treatment of pain at sexual activity (dyspareunia) with intravaginal dehydroepiandrosterone (prasterone)David F Archer, Fernand Labrie, Céline Bouchard, et al.
Menopause (New York, N.Y.)|December 12, 2018
Women's experience of vulvovaginal symptoms associated with menopauseJan L Shifren, Rebekah Zincavage, Ellen L Cho, et al.
Women'S Health (London, England)|May 17, 2016
Bremelanotide for female sexual dysfunctions in premenopausal women: a randomized, placebo-controlled dose-finding trialAnita H Clayton, Stanley E Althof, Sheryl Kingsberg, et al.
Menopause (New York, N.Y.)|May 14, 2015
Lack of effect of intravaginal dehydroepiandrosterone (DHEA, prasterone) on the endometrium in postmenopausal womenDavid J Portman, Fernand Labrie, David F Archer, et al.
Future Oncology (London, England)|April 13, 2025
ELAINE 3: phase 3 study of lasofoxifene plus abemaciclib to treat ER+/HER2-, <i>ESR1</i>-mutated, metastatic breast cancerMatthew P Goetz, Seth A Wander, Thomas Bachelot, et al.
Pageof 3